VOD
Showing 1 - 25 of 122
Pharmacogenetics of VOD in Children With HSCT
Completed
- Cancer
-
Paris, FranceRobert Debre Hospital
Apr 15, 2022
Veno-occlusive Disease, Child Trial in Seoul (lipoprostaglandin E1)
Active, not recruiting
- Veno-occlusive Disease
- Child
- lipoprostaglandin E1
-
Seoul, Chongno-gu, Korea, Republic ofSeoul National University Hospital
Mar 28, 2021
Sinusoidal Obstruction Syndrome, Veno-occlusive Disease, Bone Marrow Transplant Complications Trial in Maywood (Defibrotide)
Recruiting
- Sinusoidal Obstruction Syndrome
- +2 more
-
Maywood, IllinoisLoyola University Medical Center
Apr 22, 2021
VOD, Ultrasound Therapy; Complications Trial in Haifa (Liver Ultrasound)
Not yet recruiting
- VOD
- Ultrasound Therapy; Complications
- Liver Ultrasound
-
Haifa, Israek, IsraelRambam Medical Center
Dec 6, 2020
Erectile Dysfunction, Erectile Dysfunction Due to Venous Disorder Trial in Cairo (Shaeer-II, PPI)
Not yet recruiting
- Erectile Dysfunction
- Erectile Dysfunction Due to Venous Disorder
- Shaeer-II
- PPI
-
Cairo, EgyptKasr El Aini Faculty of Medicine, Cairo University
Nov 6, 2023
Erectile Dysfunction Trial in Cairo (Shaeer-I, PPI)
Not yet recruiting
- Erectile Dysfunction
- Shaeer-I
- PPI
-
Cairo, EgyptKasr El Aini Faculty of Medicine, Cairo University
Nov 6, 2023
Sinusoidal Obstruction Syndrome, Veno-occlusive Disease Trial (Defibrotide)
Not yet recruiting
- Sinusoidal Obstruction Syndrome
- Veno-occlusive Disease
- (no location specified)
Aug 4, 2023
Veno-occlusive Disease Trial in Worldwide (Defibrotide, Best Supportive Care)
Completed
- Veno-occlusive Disease
- Defibrotide
- Best Supportive Care
-
Birmingham, Alabama
- +113 more
Feb 4, 2022
Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou
Recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation
- +2 more
- VEN+AZA+Modified BUCY
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Apr 10, 2023
Allogeneic Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia Trial in Suzhou (VEN+AZA+Modified BUCY)
Recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation
- Acute Lymphoblastic Leukemia
- VEN+AZA+Modified BUCY
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Apr 10, 2023
Patients With COVID-19 Pneumonia Will Allow to Detect an Absolute Reduction in the Rate of Respiratory-failure Trial in Milano
Completed
- Patients With COVID-19 Pneumonia Will Allow to Detect an Absolute Reduction in the Rate of Respiratory-failure
- Defibrotide Injection
-
Milano, Lombardia, ItalyOspedale San Raffaele
Jul 18, 2022
Relapsed Acute Myeloid Leukaemia Trial (Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL))
Not yet recruiting
- Relapsed Acute Myeloid Leukaemia
- Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL)
- (no location specified)
Jul 4, 2023
Patients Who Received Inotuzumab Ozogamicin for B-cell ALL That
Not yet recruiting
- Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
- Inotuzumab Ozogamicin
- (no location specified)
Nov 3, 2022
Penile Helicine Circulation in Veno-occlusive Erectile
Completed
- Erectile Dysfunction Due to Arterial Disease
- Ultrasound and doppler
-
Latina, Italy
- +1 more
Mar 25, 2022
Hepatic Veno-Occlusive Disease, Nephroblastoma, Acute Lymphoblastic Leukemia Trial in France (Blood test for genetic analysis)
Unknown status
- Hepatic Veno-Occlusive Disease
- +2 more
- Blood test for genetic analysis
-
Amiens, France
- +15 more
Nov 15, 2019
MDS, Secondary Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Aachen, Düsseldorf, Jena (Venetoclax, Amsacrine,
Not yet recruiting
- Myelodysplastic Syndromes
- +2 more
- Venetoclax
- +4 more
-
Aachen, NRW, Germany
- +2 more
Mar 29, 2023
InO - A Retrospective Study of UK Patients With Leukaemia
Completed
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Inotuzumab Ozogamicin
-
Bristol, United Kingdom
- +3 more
Jan 27, 2022
European VOD Registry
Completed
- Hepatic Veno-Occlusive Disease
-
Angers, France
- +52 more
Oct 14, 2019
Leukemia, Precursor b-Cell Lymphoblastic Leukemia-Lymphoma, ACUTE LYMPHOBLASTIC LEUKEMIA Trial in Worldwide (inotuzumab
Active, not recruiting
- Leukemia
- +2 more
- inotuzumab ozogamicin-dose level 2
- Inotuzumab ozogamicin-dose level 1
-
Los Angeles, California
- +45 more
Mar 9, 2022
Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Blasts 5 Percent or More of Bone Marrow Nucleated Cells, Blasts 5
Withdrawn
- Allogeneic Hematopoietic Stem Cell Transplantation Recipient
- +7 more
- Inotuzumab Ozogamicin
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 13, 2022
Sickle Cell Disease Trial in Atlanta (procedure, drug, other, radiation)
Recruiting
- Sickle Cell Disease
- Bone Marrow Transplant (BMT)
- +7 more
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta
Sep 13, 2022
The Endothelial Cell Dysfunction and Outcome Project for
Not yet recruiting
- Hematological Neoplasm
- Endothelial Dysfunction
- Sublingual in vivo microscopy with the Glycocheck microscope
- (no location specified)
Aug 14, 2022
Tumor Tissue Samples From Young Acute Lymphoblastic Leukemia
Completed
- Childhood Acute Lymphoblastic Leukemia in Remission
- Recurrent Childhood Acute Lymphoblastic Leukemia
- Laboratory Biomarker Analysis
-
Philadelphia, PennsylvaniaChildrens Oncology Group
Aug 12, 2022